// startup autopsy
PainCeptor Pharma
Chasing pain relief, caught in a funding drought
marketfitSilent Shutdown
Quiet closure with no public announcement · Fatal mistake: Failed to advance drug candidates to a fundable clinical milestone before the 2007 funding dried up, leaving no path to Series B.
Key Events Timeline
FOUNDING
PainCeptor Pharma founded in Canada to develop novel pain therapeutics targeting ion channels.
FUNDING
Company closes its final funding round raising approximately $20.7M total, focused on advancing pain drug candidates.
REGULATORY ACTION
Clinical pipeline stalls as regulatory requirements demand more robust efficacy data, depleting remaining cash reserves.
SHUTDOWN
PainCeptor Pharma quietly shuts down after failing to raise additional capital or find an acquirer for its pain therapeutic assets.